hydration benefits glp-1 receptor agonists Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1 receptor agonists and next-generation
Description
doi: 10.7759/cureus.29262

A retrospective disproportionality analysis was conducted using the reporting odds ratio (ROR) on FAERS data (20042024), with Bayesian confidence propagation neural network (BCPNN) employed for sensitivity analysis

The medication demonstrates substantial efficacy in reducing hemoglobin A1c levels and promoting weight loss, with reductions of up to 21% of body weight observed in clinical trials of patients with obesity without diabetes, and approximately 12-15% in those with type 2 diabetes

New York: Garland Science

As such, this data is not directly comparable to Wegovys SELECT

notify a healthcare professional if upper-right abdominal pain, fever, or jaundice develops
